Post by PressReleaseon Nov 04, 2022 6:48am
15 Views
Post# 35072164
New Press Release - Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine